X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49006) 49006
Newspaper Article (185) 185
Book Chapter (118) 118
Book / eBook (81) 81
Magazine Article (81) 81
Newsletter (52) 52
Conference Proceeding (17) 17
Web Resource (11) 11
Dissertation (7) 7
Book Review (5) 5
Publication (5) 5
Government Document (4) 4
Reference (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43613) 43613
male (24866) 24866
female (24127) 24127
bone neoplasms - secondary (18656) 18656
middle aged (17551) 17551
oncology (14847) 14847
adult (14041) 14041
aged (13945) 13945
cancer (8772) 8772
metastasis (7793) 7793
animals (7220) 7220
tumors (5906) 5906
adolescent (5810) 5810
bone neoplasms - pathology (5691) 5691
treatment outcome (5521) 5521
prognosis (5258) 5258
surgery (5239) 5239
hematology (5041) 5041
aged, 80 and over (4978) 4978
retrospective studies (4950) 4950
chemotherapy (4917) 4917
bone marrow (4849) 4849
bone neoplasms - diagnostic imaging (4669) 4669
child (4667) 4667
care and treatment (4626) 4626
bone neoplasms - drug therapy (4489) 4489
mice (4348) 4348
breast neoplasms - pathology (4346) 4346
medicine & public health (3973) 3973
research (3740) 3740
lung neoplasms - secondary (3738) 3738
breast cancer (3595) 3595
cell line, tumor (3574) 3574
prostatic neoplasms - pathology (3547) 3547
follow-up studies (3499) 3499
analysis (3291) 3291
expression (3262) 3262
radiology, nuclear medicine & medical imaging (3235) 3235
health aspects (3155) 3155
tomography, x-ray computed (3118) 3118
diagnosis (3092) 3092
bone neoplasms - diagnosis (3083) 3083
bone neoplasms - surgery (2997) 2997
bone (2958) 2958
metastases (2935) 2935
risk factors (2932) 2932
survival (2867) 2867
young adult (2837) 2837
orthopedics (2804) 2804
patients (2777) 2777
stem cells (2737) 2737
pathology (2731) 2731
prostate cancer (2710) 2710
antineoplastic combined chemotherapy protocols - therapeutic use (2675) 2675
neoplasm staging (2656) 2656
magnetic resonance imaging (2635) 2635
osteosarcoma (2623) 2623
leukemia (2614) 2614
bone cancer (2536) 2536
diagnosis, differential (2516) 2516
combined modality therapy (2493) 2493
therapy (2493) 2493
carcinoma (2489) 2489
child, preschool (2486) 2486
radionuclide imaging (2478) 2478
neoplasm metastasis (2464) 2464
bone metastases (2438) 2438
transplantation (2395) 2395
bone neoplasms - metabolism (2301) 2301
radiography (2275) 2275
bone neoplasms - therapy (2273) 2273
survival rate (2225) 2225
radiotherapy (2186) 2186
breast-cancer (2164) 2164
immunohistochemistry (2141) 2141
apoptosis (2136) 2136
time factors (2118) 2118
gene expression (2090) 2090
medicine (2089) 2089
antineoplastic agents - therapeutic use (2074) 2074
disease (2054) 2054
bone neoplasms - radiotherapy (2007) 2007
cell biology (2006) 2006
proteins (2000) 2000
lung neoplasms - pathology (1989) 1989
bone neoplasms - complications (1953) 1953
bone-marrow (1945) 1945
biopsy (1914) 1914
development and progression (1894) 1894
liver neoplasms - secondary (1890) 1890
bone metastasis (1878) 1878
bone marrow - pathology (1834) 1834
research article (1817) 1817
immunology (1779) 1779
hematology, oncology and palliative medicine (1756) 1756
cancer therapies (1734) 1734
survival analysis (1718) 1718
disease progression (1714) 1714
bone-marrow-transplantation (1697) 1697
breast neoplasms - drug therapy (1690) 1690
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (29) 29
Online Resources - Online (16) 16
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Baycrest Hospital - Oversize (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reference (1) 1
Mt Sinai Hospital - Pathology (1) 1
Robarts - Stacks (1) 1
Sunnybrook Health Sciences Centre - Missing (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (45529) 45529
Japanese (1147) 1147
German (1019) 1019
French (863) 863
Spanish (396) 396
Chinese (320) 320
Russian (246) 246
Italian (224) 224
Polish (143) 143
Czech (65) 65
Hungarian (64) 64
Danish (49) 49
Dutch (41) 41
Portuguese (36) 36
Turkish (20) 20
Korean (14) 14
Romanian (14) 14
Serbian (13) 13
Hebrew (12) 12
Croatian (10) 10
Norwegian (10) 10
Bulgarian (9) 9
Swedish (9) 9
Finnish (8) 8
Slovak (7) 7
Lithuanian (5) 5
Ukrainian (5) 5
Arabic (3) 3
Greek (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT) for metastases limited in number and extent.... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Abstract Purpose To assess preliminary safety and efficacy results of the anti-programmed cell death ligand-1 (anti-PD-L1) durvalumab in combination with... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 65, Issue 2, pp. 270 - 273
Journal Article
The Journal of pathology, ISSN 0022-3417, 2014, Volume 232, Issue 1, pp. 23 - 31
Journal Article
Nature cell biology, ISSN 1476-4679, 2013, Volume 15, Issue 7, pp. 807 - 817
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 03/2013, Volume 8, Issue 3, pp. 346 - 351
Journal Article
American Journal of Pathology, ISSN 0002-9440, 2010, Volume 177, Issue 4, pp. 1647 - 1656
Phosphatase and tensin homolog (PTEN) is a key modulator of trastuzumab sensitivity in HER2-overexpressing breast cancer. Because PTEN opposes the downstream... 
ADJUVANT CHEMOTHERAPY | INHIBITION | THERAPY | PROTEIN | HUMAN-BREAST-CANCER | PATHWAY | MUTATIONS | PATHOLOGY | RECEPTORS | TRASTUZUMAB RESISTANCE | EXPRESSION | Lung Neoplasms - drug therapy | Receptors, Estrogen - metabolism | Receptor, ErbB-2 - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | Young Adult | Carcinoma, Ductal, Breast - drug therapy | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Proto-Oncogene Proteins c-akt - metabolism | Carcinoma, Ductal, Breast - metabolism | PTEN Phosphohydrolase - genetics | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Survival Rate | Lymphatic Metastasis | Brain Neoplasms - drug therapy | Mutation - genetics | Breast Neoplasms - drug therapy | Class I Phosphatidylinositol 3-Kinases | Carcinoma, Lobular - metabolism | Trastuzumab | Bone Neoplasms - mortality | Phosphorylation | Prognosis | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Liver Neoplasms - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Brain Neoplasms - secondary | In Situ Hybridization | Lung Neoplasms - secondary | Adult | Female | Bone Neoplasms - drug therapy | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | PTEN Phosphohydrolase - metabolism | Phosphatidylinositol 3-Kinases - genetics | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - drug therapy | Regular
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 6, pp. 976 - 983
Purpose To evaluate trastuzumab (H) and docetaxel (T) with or without capecitabine (X) as first-line combination therapy for human epidermal growth factor... 
SURVIVAL | COMBINATIONS | MULTICENTER | AMPLIFICATION | THERAPY | EFFICACY | ONCOLOGY | SAFETY | PRETREATED PATIENTS | ANTIBODY | PACLITAXEL | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Bone Neoplasms - secondary | Soft Tissue Neoplasms - drug therapy | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Feasibility Studies | Young Adult | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Fluorouracil - analogs & derivatives | Soft Tissue Neoplasms - secondary | Deoxycytidine - administration & dosage | Liver Neoplasms - drug therapy | Soft Tissue Neoplasms - metabolism | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | International Agencies | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Liver Neoplasms - metabolism | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Trastuzumab | Liver Neoplasms | Breast Neoplasms | Life Sciences | Immunology | Taxoids | Fluorouracil | Antineoplastic Combined Chemotherapy Protocols | Antibodies, Monoclonal | Bone Neoplasms | Receptor, erbB-2 | Deoxycytidine | Soft Tissue Neoplasms
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 1945-7197, 2006, Volume 91, Issue 8, pp. 2892 - 2899
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 2011, Volume 12, Issue 6, pp. 380 - 386
Micro-Abstract We evaluated EGFR and KRAS mutations between 37 paired primary tumors and corresponding metastases in lung adenocarcinoma. A substantial... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Lung adenocarcinoma | Metastasis | Mutation | Epidermal growth factor receptor | Pleura | GENE-MUTATIONS | PRIMARY TUMORS | GEFITINIB | GROWTH-FACTOR-RECEPTOR | KRAS MUTATION | TREATED PATIENTS | CANCER | LYMPH-NODE METASTASIS | ONCOLOGY | BRAIN METASTASES | PROGRESSION | Adrenal Gland Neoplasms - drug therapy | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Pleural Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Pleural Neoplasms - drug therapy | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Polymerase Chain Reaction | Aged, 80 and over | Adrenal Gland Neoplasms - secondary | Adult | Female | Adenocarcinoma - genetics | Bone Neoplasms - genetics | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Lung Neoplasms - genetics | Pleural Neoplasms - secondary | Liver Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Liver Neoplasms - drug therapy | Brain Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Brain Neoplasms - drug therapy | Mutation - genetics | Adenocarcinoma - drug therapy | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | DNA, Neoplasm - genetics | Neoplasm Staging | Adrenal Gland Neoplasms - genetics
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 880 - 887
Purpose Although palliative chemotherapy is the standard of care for patients with diagnoses of stage IV non-small cell lung cancer (NSCLC), patients with a... 
Radiology | Hematology, Oncology and Palliative Medicine | ADRENAL METASTASES | SURVIVAL | RADICAL TREATMENT | PHASE-II-TRIAL | MANAGEMENT | PROGNOSTIC-FACTORS | BRAIN METASTASIS | ONCOLOGY | RESECTION | SURGICAL-TREATMENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Bone Neoplasms - mortality | Bone Neoplasms - therapy | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | Carcinoma, Squamous Cell - diagnostic imaging | Adrenal Gland Neoplasms - mortality | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Adrenal Gland Neoplasms - secondary | Female | Retrospective Studies | Brain Neoplasms - mortality | Databases, Factual | Carcinoma, Non-Small-Cell Lung - pathology | Severity of Illness Index | Carcinoma, Squamous Cell - therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Radiography | Propensity Score | Carcinoma, Non-Small-Cell Lung - therapy | Analysis of Variance | Brain Neoplasms - therapy | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - diagnostic imaging | Aged | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Neoplasm Staging | Adrenal Gland Neoplasms - therapy | Lung cancer, Small cell | Chemotherapy | Lung cancer, Non-small cell | Cancer | DIAGNOSIS | PATIENTS | NEOPLASMS | LUNGS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | HISTOLOGY | CHEMOTHERAPY | HAZARDS
Journal Article